Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Pliant Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 88 | 1 | 110 | +23 |
| Shares | 30.1M | 234 | 45.4M | +15.3M (+50.6%) |
| Value | $241.5M | $1.87K | $948.1M | +$706.7M (+292.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 484,524 | $3.88M |
| Laurion Capital Management LP | 470,601 | $3.77M |
| State of Wisconsin Investment Board | 78,200 | $626.0K |
| Marshall Wace, LLP | 46,414 | $371.0K |
| Algert Global LLC | 36,020 | $289.0K |
| PDT Partners, LLC | 24,378 | $195.0K |
| Cornercap Investment Counsel Inc | 24,280 | $194.0K |
| HSBC Holdings PLC | 18,070 | $144.0K |
| Delphia (USA) Inc. | 17,177 | $138.0K |
| Corton Capital Inc. | 15,747 | $126.0K |
| Belvedere Trading LLC | 6,490 | $125.0K |
| XTX Topco Ltd | 15,581 | $125.0K |
| Caption Management, LLC | 11,000 | $88.0K |
| Acadian Asset Management LLC | 10,753 | $86.0K |
| Graham Capital Management, L.P. | 10,202 | $81.0K |
| Salem Investment Counselors Inc | 7,735 | $62.0K |
| Jefferies Group LLC | 6,799 | $54.5K |
| Quantbot Technologies LP | 2,017 | $16.0K |
| Captrust Financial Advisors | 612 | $5.00K |
| Laurel Wealth Advisors LLC | 160 | $1.00K |
| Credit Suisse AG | 13 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 234 | $1.87K |